{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-043844","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2026-09-23T13:21:42+00:00","discovered_at":"2026-09-23T13:23:01.044807+00:00","generated_at":"2026-09-23T13:23:12.229874+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Glucotrack (Lōkahi) advances LT-100, submits protocol; ai² platform flags 45 assets","bullets":["Completed strategic business combination on July 14, 2026; Glucotrack Technologies now wholly owned subsidiary.","LT-100 for osteoarthritis knee pain: clinical protocol submitted for regulatory review; targeting near-term study start.","Planned study evaluates once-weekly subcutaneous injection vs historical 15 weekly intradermal injections.","ai² platform has 14 university partners, screening 12,000+ abandoned late-stage programs; 45 assets met initial criteria.","Qare first ai² Accelerator initiative; business model aims to monetize assets before registration trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-043844","json":"https://secwatch.observer/filing/0001493152-26-043844.json","markdown":"https://secwatch.observer/filing/0001493152-26-043844.md","text":"https://secwatch.observer/filing/0001493152-26-043844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226043844/0001493152-26-043844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226043844/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T13:23:12.229874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}